420 related articles for article (PubMed ID: 9528994)
21. Induction and expression of cyclin D3 in human pancreatic cancer.
Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
[TBL] [Abstract][Full Text] [Related]
22. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1.
Robker RL; Richards JS
Mol Endocrinol; 1998 Jul; 12(7):924-40. PubMed ID: 9658398
[TBL] [Abstract][Full Text] [Related]
23. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms.
Winston JT; Pledger WJ
Mol Biol Cell; 1993 Nov; 4(11):1133-44. PubMed ID: 8305735
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
Sicinski P; Donaher JL; Geng Y; Parker SB; Gardner H; Park MY; Robker RL; Richards JS; McGinnis LK; Biggers JD; Eppig JJ; Bronson RT; Elledge SJ; Weinberg RA
Nature; 1996 Dec; 384(6608):470-4. PubMed ID: 8945475
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
Chen Q; Lin J; Jinno S; Okayama H
Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
27. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
28. Basic fibroblast growth factor exhibits dual and rapid regulation of cyclin D1 and p27 to stimulate proliferation of rat cerebral cortical precursors.
Li B; DiCicco-Bloom E
Dev Neurosci; 2004; 26(2-4):197-207. PubMed ID: 15711060
[TBL] [Abstract][Full Text] [Related]
29. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to mammalian D-type G1 cyclins.
Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
Dey A; Li W
Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
[TBL] [Abstract][Full Text] [Related]
34. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
35. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Moore GD; Ayabe T; Kopf GS; Schultz RM
Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
[TBL] [Abstract][Full Text] [Related]
36. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
[TBL] [Abstract][Full Text] [Related]
37. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
38. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
39. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
Ko TC; Sheng HM; Reisman D; Thompson EA; Beauchamp RD
Oncogene; 1995 Jan; 10(1):177-84. PubMed ID: 7824270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
